Surveying Tuberculosis Screening Practices of South Carolina Hospital Employees by Carree, Tamara T.
University of South Carolina 
Scholar Commons 
Theses and Dissertations 
Spring 2020 
Surveying Tuberculosis Screening Practices of South Carolina 
Hospital Employees 
Tamara T. Carree 
Follow this and additional works at: https://scholarcommons.sc.edu/etd 
 Part of the Clinical Epidemiology Commons 
Recommended Citation 
Carree, T. T.(2020). Surveying Tuberculosis Screening Practices of South Carolina Hospital Employees. 
(Master's thesis). Retrieved from https://scholarcommons.sc.edu/etd/5956 
This Open Access Thesis is brought to you by Scholar Commons. It has been accepted for inclusion in Theses and 
Dissertations by an authorized administrator of Scholar Commons. For more information, please contact 
dillarda@mailbox.sc.edu. 
 




 Tamara T. Carree 
 
Bachelor of Science 
Benedict College, 2007 
 
 
Submitted in Partial Fulfillment of the Requirements 
 




The Norman J. Arnold School of Public Health 
 






Eric Brenner, Director of Thesis 
 
Linda Hazlett, Director of Thesis 
 
Robert Moran, Reader 
 
Cheryl L. Addy, Vice Provost and Dean of the Graduate School
ii 
 





 I would like to acknowledge Dr. Rick Foster, Mr. Jimmy Walker, and the South 




BACKGROUND: Every year tuberculosis causes over 10 million cases globally and in 
recent years has caused over 9,000 cases annually in the United States. TB can be 
transmitted in hospital settings, and South Carolina hospitals, like hospitals elsewhere  in 
the country, maintain a responsibility to test their employees for this disease. Nosocomial 
infections of active TB among patients and healthcare workers can be burdensome on 
hospital resources. Testing healthcare workers and implementing prevention strategies are 
examples of administrative controls provided in the 2005 guidelines by the Centers for 
Disease Control and Prevention (CDC). Implementation of  administrative controls are 
considered the most important and are the first tier of the hierarchical control strategies for 
preventing TB transmission in healthcare settings. 
 OBJECTIVE: The purpose of this study was to review current employee TB screening 
practices in South Carolina hospitals, in particular to assess (i) whether they screen using 
the traditional tuberculin skin test or the newer Interferon Gamma Release Assay; and (ii) 
whether they have (or have not) performed a formal TB risk assessment following 
suggested administrative  prevention  controls from guidelines by the CDC. 
METHODS: Utilizing the TB Risk Assessment for healthcare facilities, a questionnaire 
was designed and distributed via Survey Monkey with the assistance of the South Carolina 
Hospital Association (SCHA) to member South Carolina healthcare facilities  (n=100). 
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RESULTS: Fifty-one health care facilities participated in the study. Forty-one facilities 
(84%) reported using the guidelines as a basis for employee TB testing, yet only thirty-four 
facilities (68%) stated that a formal risk assessment had been performed prior to the survey.
CONCLUSION: The majority of South Carolina hospitals surveyed are adhering to CDC 
testing guidelines for healthcare employees and conducting a formal risk assessment. 
Additional training and guidance with  all hospital employees would be beneficial in 
providing consistency of policy implementation across the state. Implementation of 
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LIST OF ABBREVIATIONS 
BCG ............................................................................................Bacillus Calmette - Guérin 
CDC ................................................................. Centers for Disease Control and Prevention 
DOT .............................................................................................. directly observed therapy 
ELISA ........................................................................ enzyme-linked immunosorbent assay 
EMB .....................................................................................................................ethambutol 
FDA......................................................................................... Federal Drug Administration 
HIV ..................................................................................... human immunodeficiency virus 
IFN-γ ........................................................................................................  interferon gamma 
IGRA ................................................................................... interferon gamma release assay 
INH ......................................................................................................................... isoniazid 
LTBI .......................................................................................... latent tuberculosis infection 
MDR-TB ............................................................................ multi-drug resistant tuberculosis 
PBMC ........................................................................... peripheral blood mononuclear cells 
PPD .............................................................................................. protein purified derivative 
PZA .................................................................................................................. pyrazinamide 
QFT ...................................................................................................................  Quantiferon  
QFT-G ....................................................................................................... Quantiferon Gold  
QFT-GIT ........................................................................................ Quantiferon Gold Intube 
RIF ........................................................................................................................... rifampin  




SP .......................................................................................................................... specificity 
TB ...................................................................................................................... tuberculosis 
TST ......................................................................................................... tuberculin skin test 





Section 1.1: Statement of the Problem 
     Global TB incidence in 2017 was 130 cases per 100,000 (The World Health 
Organization 2018). The number of new cases in the United States was 2.9 per 100,000 
persons (CDC 2018).  At the local level, South Carolina reported 2 new cases per 100,000 
of tuberculosis in the state in 2017 (SCDHEC 2018). Although prior to 2009, South 
Carolina TB incidence rates were greater than the national TB incidence rates, recent  data 
show the reverse to be true (Arden 2013) [Figure 1.1]. 
Infections spread in healthcare settings require not only time and investigation but also 
tracking and treating those possibly infected. This can become especially difficult when a 
healthcare facility is in a large metropolitan area in which the population (including 
healthcare workers and patients) is continually changing. Nosocomial TB infections which 
are latent or present asymptomatically can be burdensome on patients, healthcare workers, 
and resources.   
Historically, occupational exposure among US healthcare workers placed them at 
higher risk for TB disease and LTBI; however, recent data suggest that like TB rates in the 
general population, rates among healthcare workers have also declined. (MMWR 2019). 
In fact, the incidence rates among healthcare workers are similar to the general population. 
Similarly, a study by Mongkolrattanothai et al found no difference in incidence rates 
between U. S. healthcare workers and the general population but reported 
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significant differences in the incidence rates between foreign- born healthcare workers 
(10.8 cases per 100,000) and US born healthcare workers (0.8 new cases per 100,000) 
(2019).  
     While, there have been no reported cases of TB exposure or transmission in South 
Carolina healthcare facilities in recent years, TB investigations in Greenwood, Rock Hill, 
and Charleston school districts have resulted in the discovery of at least 2 cases of active 
TB. High profile incidents of tuberculosis exposure in health care facilities in New York 
and Texas also emphasized the need to assess guidelines provided to healthcare facilities 
to prevent transmission of the disease among healthcare patients and workers.   
Section 1.2 Purpose of the Study 
     The purpose of this study is to describe global, national, and local TB incidence and to 
assess the utilization of administrative controls outlined in the CDC 2005 guidelines by 
healthcare facilities in South Carolina hospitals.  Administrative controls reduce the risk of 
exposure to infectious TB. These preventive measures include but are not limited to 
establishing and implementing an infection control program, educating, training, and 
counseling personnel, patients, and visitors about TB, screening staff, and conducting a 
risk assessment of the facility. This study focused specifically on the following 
administrative controls: hospital TB screening tests, hospital employee TB screening 
procedures, and completion of a hospital risk assessment. Evaluating these administrative 
controls could have implications to re-evaluate current recommendations and to modify  





Figure 1.1 TB Incidence per 100,000 Persons for  South Carolina  and United States, 








































     Mycobacterium tuberculosis (MTB), a tubercle bacilli, is the causal agent for 
tuberculosis (TB).  The mycobacterium is resistant to drying and water-based bacterial 
agents. TB is an airborne disease spread through droplet nuclei from an infectious person 
and is transmitted primarily through the respiratory tract, although it can also enter the 
body through mucous membranes and breaks in the skin (Belknap and Daley 2014). 
Clinical manifestations of TB are presented in three forms: pulmonary, extra pulmonary, 
and miliary. Pulmonary TB is found in 80% of cases which occur in  immunocompetent 
persons.  Symptoms include chest pain, productive cough with or without a bloody sputum, 
anorexia, fatigue, fever, and chills. Extrapulmonary TB is common in children and 
immunocompromised persons, and the symptoms are fatigue, night sweats, and issues with 
the organ system infected. Miliary TB is also found in children and the immunosuppressed; 
it essentially produces small nodules that infect every organ. 
 Symptoms of miliary TB are also dependent upon the organs affected in the body.   
Although TB usually affects the lungs, any tissue or organ of the body (i.e. spine, lymph 
nodes, heart, or brain) (Golub et al, 2014) may be infected. Once bacteria-laden droplet 
nuclei reach the alveoli of the lungs, multiplication occur causing latent tuberculosis 
infection and tuberculosis disease. Latent tuberculosis infection (LTBI) refers to being 
infected with TB bacteria but the body’s immune system prevents sickness and
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 infectiousness from occurring in an individual. If the body discontinues fighting the 
bacteria, the bacteria can multiply, and the individual can develop TB disease. 
      Currently, the tuberculin skin test (TST) and interferon gamma release assays (IGRAs) 
are used for routine screening for LTBI. TST and IGRAs are also used in conjunction with 
chest x-rays and sputum collection to test for TB infection in patients being evaluated for 
LTBI or the actual disease. Treatment of all three forms of TB disease consists of treatment 
in two phases with a combination of isoniazid, rifampin, pyrazinamide, and ethambutol for 
6 to 9 months [Table 2.1] . Observation of each dose of medication, also known as directly 
observed therapy (DOT) is the now universally recognized as the “standard of care” for 
treatment of TB disease. In 1921, tuberculosis became one of the first diseases to have a 
vaccine. The vaccine, created by Albert Calmette and Camille Guérin  named  Bacillus 
Calmette-Guérin or BCG, was used quite commonly in Europe to lessen the burden of the 
disease (Golub, Coberly, & Chaisson, 2014). BCG is still used in many developing 
countries today to vaccinate infants and healthcare workers.  
Section 2.2 Screening Tests 
     Many of the signs and symptoms of TB disease are nonspecific, and LTBI is 
asymptomatic, which makes diagnosing TB reliant on screening test to  identify those who 
have disease. Multiple screening tests have been developed over the years, and some 
screening tests have been used at the same time. Current screening tests include a) the 
tuberculin skin test (TST), b) Quantiferon Gold Intube (QFT-GIT), c) and T-spot. The 
sensitivity and specificity of these tests, as documented by the CDC, are provided in Table 
2.2 (MMWR 2010). There are two variations of the TST test, one-step TST and the two-
step TST. The two-step TST is used to test new employees that will be tested periodically 
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for TB infection. Two-step TST screening requires persons who test negative during first 
TST to then have another TST test.  While the single or one-step TST test, is the one-time 
injection of PPD and then a follow-up visit to have the test read.  
Several factors affect the agreement of these tests including test interpretation criteria, 
prevalence of infection, prior BCG vaccination, and co-infection of other diseases.  
 Some health care facilities use IGRAS in serial testing of workers since CDC guidelines 
state that in all circumstances in which TST is the current testing method, IGRAS can be 
substituted in place of the TST. However, serial testing health care workers in low 
incidence areas with IGRAS results in a decrease in the predictive value of a positive test 
(Slater 2013). With the availability of multiple tests  for screening, deciding which test to 
utilize can add to the complexity of  screening healthcare workers. 
Section 2.3: Tuberculosis in Healthcare Settings 
Hospitals in the U.S. have experienced TB transmission from healthcare workers 
to patients. TB transmission occurred in 2003 in the maternity ward and nursery at a New 
York hospital.  Approximately 1500 patients were exposed to infectious pulmonary TB 
disease by a foreign-born nurse who had been diagnosed with latent TB infection but 
refused treatment (MMWR 2005).  The majority of those exposed could not be located for 
testing, but it was found that four infants had positive TST results (2005). In Texas in 2014, 
over 700 infants and 40 employees were exposed to TB by a nurse with TB disease working 
in an El-Paso hospital.  Subsequent testing found five babies tested positive for TB. It was 
later found that four of the five babies who tested positive were also vaccinated with BCG, 
which may have resulted in false positives (Bailey 2014).
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Section 2.4: South Carolina Hospital Association 
 Created to set and reach appropriate standards of care, the South Carolina Hospital 
Association (SCHA) aims to keep patients in the state safe and healthy. SCHA is a private 
non-profit organization comprised of 100 member hospitals and health systems (e.g. 
substance abuse centers). Member healthcare facilities range in size from 14 beds to 864 
beds. As of 2018, there are 104 hospitals in the state. 
 Section 2.5: CDC TB Transmission Guidelines  
‘Guidelines for Preventing the Transmission of Mycobacterium tuberculosis in 
Health-Care Settings, 2005’, the TB transmission guidelines for healthcare facilities 
published by the CDC, were a result of several factors (MMWR 2005). Previous guidelines 
issued first in 1992 and updated in 1994 suggested controlling TB in healthcare facilities 
through a risk assessment process that corresponded to environmental and respiratory 
protection. Because of the successful implementation of the 1994 recommendations, TB 
transmission within healthcare facilities declined.  
The guidelines were restructured in 2005 to reflect the changing TB trends in the 
US, changes in medical practice, and current understanding of the disease.  The 2005 CDC 
guidelines included updates to improve risk assessments, frequency and criteria for testing 
of healthcare employees, and the types of facilities covered (MMWR 2005). The guidelines 
provided recommendations primarily for inpatient facilities where healthcare is provided. 
Divided into hierarchical tiers (administrative controls, environmental controls, and 
respiratory-protection controls), the guidelines aimed to maintain momentum and to 
eliminate the threat of nosocomial transmission. These controls were essential in the 
reduction of TB transmission in health care facilities however notable differences in rates 
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within geographic areas remained. Thus, depending upon the region, the risk associated 
with tuberculosis transmission among health care workers would vary. 
Per 2005 CDC guidelines, environmental controls consist of ventilation and 
filtration in healthcare settings to control and to minimize the spread of infectious droplets, 
and respiratory protection controls limit the risk of exposure in high risk situations through 
respiratory equipment. This study focused on administrative controls (testing practices 
specifically). The goal of administrative controls is to reduce the risk of TB infection 
(MMWR 2005). Administrative controls include conducting facility risk assessments, 










Table 2.1 Tuberculosis Treatment Regimens 
 Intensive Phase Continuation Phase  










































































































































Table 2.2:  Tuberculosis Screening Tests 
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In order to determine hospital compliance with the 2005 CDC TB guidelines, we 
needed to contact all 100 health care facilities in South Carolina. We developed questions 
for use as part of a questionnaire (Appendix A).  Specifically, survey questions focused on 
a) which employees were being screened for TB, b) the frequency of employee testing, and 
c) whether the hospital had performed a risk assessment (Appendix B) in accordance with 
the 2005 CDC guidelines. Initial draft of questions was from the risk assessment (Appendix 
D). SCHA expressed concerns in regards privacy of facilities’ data and survey length. The 
questions were redrafted and restructured to shorten the survey and address privacy whilst 
still probing for the information that was of interest to the study. Six questions stemmed 
from the TB risk assessment and 4 questions were the product of the study and the SCHA.   
Facilities were also asked for suggestions or comments that would be beneficial for TB 
control in the facility. Although the response rate was high (51%) , data were missing for 
some questions. 
We collaborated with the South Carolina Hospital Association (SCHA) in the 
survey development and administration, because they were familiar to hospitals in South 
Carolina and had greater access to this population. Once survey questions were developed, 
the SCHA edited, formatted and organized the 11 questions into a questionnaire 




 our questionnaire, notifying the infection control employee completing the questionnaire 
of the study purpose, how the information would be used, and that participation was 
voluntary.  Survey Monkey® was used, because the SCHA had used this website 
previously to collect information from hospitals. The survey was deployed in April 2015. 
The data were compiled by the SCHA who provided the final data in an Excel spreadsheet. 
A calculator was also developed in Microsoft Excel to calculate the specificity, sensitivity, 








SOUTH CAROLINA HOSPITAL ASSOCIATION STUDY 
BACKGROUND:  Seven hundred babies were exposed to TB in a Texas hospital nursery by 
a hospital employee from August 2013 to September 2014 (Arden 2013), and a nursery 
and maternity ward in New York City in 2003 reported TB transmission from a nurse to 4 
infants (Santora 2005). With Centers for Disease Control (CDC) guidelines to prevent TB 
transmission in health care settings and advancements in testing, these isolated incidents 
highlight a deficiency in infection control measures. Implementation of CDC guidelines 
are important in sustaining the decline of TB in United States especially in South Carolina 
which often historically ranked in the top ten states with the highest TB case rates. 
PURPOSE: The purpose of this study is to determine the use of the Centers for Disease 
Control and Prevention guidelines for preventing the transmission of Mycobacterium 
tuberculosis in health-care settings, 2005 in South Carolina health-care facilities. 
METHODS: A voluntary questionnaire was compiled in collaboration with the South 
Carolina Hospital Association (SCHA) and administered via Survey Monkey by the 
SCHA. 
RESULTS: Fifty-one percent (51%) of member facilities of the South Carolina Hospital 
Association completed the survey. Eighty-four percent of participating facilities were 
aware of the CDC TB Risk Assessment Guidelines. Furthermore, sixty-eight percent of 





testing. Eighty percent of facilities thought periodic TB training for hospital staff would be 
beneficial. Sixty-four percent facilities reported that outside assistance for didactic 
informational sessions on infectious diseases for employees would be useful. 
CONCLUSION: The majority of South Carolina healthcare facilities are currently 
performing risk assessments and utilizing the CDC Risk Assessment Guidelines (2005) for 
employee TB screening. Despite being classified as low risk facilities, there is continued 
annual testing of all employees. This may be indicative of some difference in policy at 
facility level and national level. A few facilities reported having policies issued to them 
from outside sources.  Implementing informational sessions for all employees regarding 
TB and other infectious disease is not only desired by facilities but would also be beneficial 
preventing nosocomial transmission. 
BACKGROUND 
     Preventing nosocomial tuberculosis transmission through the screening of health care 
workers is fundamental for infection control programs.  The southern United States has 
historically had high incidence rates of tuberculosis. South Carolina until 2009 had case 
rates above the national case rate of TB (Arden 2013). The CDC  has had guidelines for 
the prevention of TB transmission but had to modify those guidelines in the 1994 due to a 
resurgence of TB, lapses in infection control measures, and co-infection of HIV (MMWR 
2005). Although there have been no recent TB outbreaks in a health care facility in South 
Carolina there have been high profile exposure incidents in Texas and New York health 
care facilities.  A state that only recently fell below the national case rate is a relevant 




of this study was to assess SC health care facilities and their compliance with the 2005 
CDC TB Guidelines. 
METHODS 
     A survey was composed through a collaboration the South Carolina Hospital 
Association. The survey was administered via Survey Monkey® and sent to 100 member 
facilities of the South Carolina Hospital Association. Questions in the survey focused on 
the facility’s current testing practices of employees and if the facility utilized the 2005  
CDC Risk Assessment as a basis for the facility’s testing policies. Facilities were also asked 
for suggestions or comments that would be beneficial for TB control in the facility. 
RESULTS 
     Fifty-one-member facilities responded to the survey of thirteen questions that probe the 
practices of South Carolina health care facilities. Thirty-four (68%) facilities reported 
conducting formal TB risk assessments per the 2005 CDC guidelines for preventing 
transmission in health care settings to assess whether all employees should be tested 
annually for TB. Sixteen (31%) of the facilities did not or were not sure if their facility 
conducted formal TB risk assessments. Although, 84% of the facilities stated that the CDC 
guidelines was used as a basis for the facility’s TB policy. Nearly all respondents (91%) 
test all employees for TB upon hire and only 2 (4%) facilities do not perform subsequent 
testing of all employees citing that they are a low risk facility and deem annual testing of 
all employees unnecessary.  
TB screening tests utilized by facilities were also relatively the same with only a 
few institutions using IGRAS solely for employee testing, although quite a few stated using 




using multiple tests for initial employee testing. Eleven facilities reported using the 
traditional TST and confirming positives with an IGRA. Majority of subsequent annual 
testing was performed using the TST and 69% of facilities reported subsequent annual 
testing of all employees.  More than half of the facilities (64%) believe additional assistance 
would be useful training for employees on not only TB but other infectious diseases.   
Surprisingly, the comments from facilities suggested a discord on the process for 
when an employee tests positive for TB. Some facilities stated having layers of steps while 
others only had a single step. One facility even stated that the steps would vary depending 
on whether the employee was diagnosed with LTBI, TB disease, or was felt to have a false 
positive test. Another facility noted that the guidelines that were adopted in their facility 
regarding TB control were provided from a corporate office of advisors. 
DISCUSSION 
     Most health care facilities in South Carolina are performing formal TB transmission 
risk assessments per the 2005 CDC TB Guidelines. However, a few facilities were not or 
were unsure if their facility had conducted a formal risk assessment. Although most 
facilities followed up employees whose test results were positive with an IGRA and chest 
x-ray, the order of testing varied from facility to facility.  Due to variations among facilities, 
it may prove beneficial to have a training or additional guidance at the state level for 
consistency across the state. 
Although the 2005 guidelines do not recommend serial testing of employees in low 
risk settings, many facilities still conducted annual testing of all employees. This may be 
the result of “tradition” in that they have always tested everyone annually or possibly the 




specificity, it is the most commonly used test for initial screenings and subsequent 
screenings in South Carolina facilities. The wide usage of the TST is possibly due to budget 
restraints of facilities as the TST is not as costly as the IGRAS.  
Despite the 2005 guidelines recommendation of annual TB education for all 
healthcare workers, 64% of   facilities indicated an interest in additional training for 
employees for a variety of infectious diseases including TB. There were also some 
questions unanswered by facilities which resulted in missing responses. The study is not 
sure if nonresponse to some questions was due to the individual answering the questions 
not knowing the response. This may be indicative of the possibility that the person the 
study wanted to target (infection control personnel and employee health personnel) was 
not the person responding to the survey.  
Eliminating nonessential testing would be beneficial during the current nationwide 
shortage of one of the TST antigens used for screening (MMWR 2019). Although IGRAS 
can be used in place of the TST, 73% of SC hospitals reported using TST for annual 
employee testing. Furthermore, recent data suggests that incidence rates of TB disease and 
LTBI among healthcare workers are consistent with the incidence rates of the general 
population. Thus, updates to the 2005 have been provided by CDC to limit employee 
testing after baseline and the absence of on-going transmissions. Recommendations for 
2019 include a personal risk assessment to be used in addition to the recommendations 
provided in 2005 (MMWR 2019). While nosocomial TB transmission is not eradicated, 
successful implementation of CDC 2005 guidelines has mitigated the threat. As the trends 
are followed, guidelines will continue to be modified to prevent TB transmission and 




Additional research should be done with health care facilities outside of the SCHA 
and with employee TB testing data to gain better representation of TB in health care 
workers in South Carolina. These factors were significant in deciding to collaborate with 
the organization however, some of the scope of the study was limited in that no 
demographic information was collected, non-response to some questions, and only member 




Table 4.1: TB Testing Practices in South Carolina Hospitals 
 Frequency Percentage No 
Response 
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Single TST only 
Two-step TST only 
Quantiferon only 
T-spot only  
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Advanced in TB infection detection and guidelines for preventing transmission in 
health care settings have resulted in low risk for TB infection for health care workers in the 
United States and in South Carolina. Until 2019, the CDC had not updated the 2005 
guidelines for tuberculosis transmission in healthcare settings. Differences in sensitivity 
and specificity of screening tests used to test hospital employees add to the complexity of 
preventing TB transmissions in hospitals as some hospitals reported using multiple tests 
within a facility. Serial testing with different tests can result in poor agreement among tests.  
In addition, the CDC has updated tuberculosis screening guidelines of health care workers 
in the United States [Appendix D]. While the new guidelines provide additional 
recommendations for screening healthcare employees, much of the old guidelines are still 
in effect. The new guidelines suggest the baseline testing of all healthcare workers in 
addition to an individual risk assessment being performed to reduce number of subsequent 
tests and not routinely screening workers without LTBI. Therefore, the new guidelines 
provide additional support that the 2005 guidelines needed to be re-assessed and modified 
to follow the trend of tuberculosis in healthcare facilities in the United States.    
Furthermore, the CDC’s 2005 guidelines for preventing TB transmission in health 
care facilities have been successful in preventing TB infection. With the new 




 resources for other purposes. Further research should seek to find whether healthcare 
facilities have additional or different guidelines at  an institutional level and what 
similarities, or differences exist between them and the national guidelines. Consistency is 
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APPENDIX A: THE SURVEY 
The Arnold School of Public Health and the South Carolina Hospital Association, in a 
collaborative effort to determine M. Tuberculosis testing policies of South Carolina 
Hospital employees, request the participation of your facility.   
All individual responses will be kept confidential and only aggregate data will be available.   
If there are any questions or concerns that you would like addressed, please contact Dr. 
Rick Foster of the South Carolina Hospital Association at rfoster@scha.org or (803) 744-
3538. 
 
We thank you in advance for your participation. 
1. Please fill out the information below. 
Name of Person completing survey: 
Name of Facility: 
 
2. Please answer the questions below. 
2a. Does your facility use the CDC Risk Assessment Recommendations published in the 
MMWR of December 30, 2005 as the basis for its employee TB policy guidelines?  
Yes  No  Not sure 
2b. Has your facility conducted a formal "TB Risk assessment" (as per the MMWR 2005 
guidelines) to help assess whether TB testing does or does not need to be conducted 
annually for all employees?  Yes  No  Not sure 
3. Are all employees tested for TB when initially hired ?  Yes No 
4. If your institution has physician clinics which are not hospital-based, do you require 
employees in these ambulatory care settings to have initial and/or subsequent 
annual TB testing?  Yes No  Not sure 
 
5. Do you conduct initial or subsequent TB testing for employees only with direct 
patient contact?  Yes No 
 




6. How is you initial TB screening conducted? (select all that apply) 
a. single "tuberculin skin test"? 
b. 2-step" tuberculin skin testing? 
c. Quantiferon Test (an IGRA test)? 
d. T-Spot test (an IGRA test)? 
e. traditional tuberculin skin test, and "positive tests" are then "confirmed with 
one of the IGRA tests 
 
7. Annual Testing (select all that apply) 
a. Subsequent annual testing is done for all employees 
b. Subsequent annual testing is done just for a subset of employees (e.g. just 
for "high-risk" employees) 
c. Subsequent annual testing is done with a traditional "tuberculin skin test" 
d. Subsequent annual testing is done just with the Quantiferon Test (an IGRA 
test) 
e. S
ubsequent annual testing is done just with the T-Spot test (an IGRA test) 
f. Subsequent annual testing is done with a traditional tuberculin skin test, and 
"positive tests" are then "confirmed with one of the IGRA 
 
8. Please answer the following: 
Does your facility conduct any periodic (e.g. annual or other?) information sessions to 
provide "basic information about TB" and to explain details about "employee TB 
testing"?  
Yes  No Not sure 
 
9. Please answer the following: 
Would outside assistance with a didactic session (e.g. annual) for employees providing 
information about infectious diseases in the hospital setting (e.g. concerning 
tuberculosis, influenza, hepatitis B, HIV, Ebola etc) be useful?  Yes   No 
  
10. What is your hospital procedure if a staff member tests positive for TB? 
 
11. What additional comments, questions or suggestions do you have 
concerning policies and training regarding infectious diseases of concern to 





APPENDIX B: PRELIMINARY HOSPITAL QUESTIONNAIRE 
1. Which of these best describes your hospital's policy? 
a) All hospital employees are tested annually 
b) Employees are tested upon hire only 
c) All employees are tested upon hire and annually thereafter 
d) Annual testing is limited to specific departments or workers (check all that apply) 
__Physicians  __Laboratory personnel   __Mid-level 
practitioners (NPs and Pas) 
__Nurses  __Maintenance or engineering staff __ Janitorial staff 
__Administrators __Transportation staff   __Dietary staff 
__Contract staff  __Students   __Service personnel 
__Construction or renovation staff     
__Other (specify) _____________________________ 
2. Which test does your facility utilize for upon hire TB screening? 
a) Two-step TST  
b) Interferon Gamma Release Assay;  
Which one:____________________________________ 
c) Symptom screen 
 
3. Which test does your facility utilize for annual testing? 
a) Two-step TST  
b) Interferon Gamma Release Essay;  
Which one:____________________________________ 
c) Symptom screen 
 
4.  How often are TB risk assessments conducted at this facility? 
a) 1> year  b) 1 per year  c) 2 ≥ per year  d) Facility does not conduct risk assessments 
 
5. How often does this facility conduct training and education for employees regarding TB 




 a) 1> year 
b) 1 per year 
c) 2 ≥ per year 
d) Facility does not conduct risk assessment 
 
6.  Does the facility utilize CDC's TB Risk Assessment Recommendations from MMWR 
December 30, 2005 for TB policy guidelines? 
a)Yes;  Facility utilizes all  of the recommendations. 
b) Yes; Facility utilizes some of the recommendations. 
c) Not Sure 
d) No; Facility utilizes none of the recommendations. 
 
7. If you answered No to the previous question, which best describes why your facility 
does not utilize CDC's TB Risk Assessment Recommendations from MMWR December 
30, 2005 for TB policy guidelines? (Check the one that best applies). 
__Not helpful   __Cumbersome  __Cost ineffective  
__Other (specify) ___________________________________________________ 
8. Have employees in your facility experienced conversion to TB disease among employees 
who previously tested negative? 
a)Yes 
b) No 
9. If you answered yes to Question 8, please indicate the following: 
a) Number of Employees:_______________________________ 
b) Primary Test Used:___________________________________ 
c) Secondary Test Used:__________________________________ 
d) If second test is different from primary test, does your facility currently use the 








10. What suggestions do you/your facility have in regards to controlling and preventing 




APPENDIX C: TB RISK ASSESSMENT WORKSHEET 
This model worksheet should be considered for use in performing TB risk assessments 
for healthcare facilities and nontraditional facility-based settings. Facilities with more 
than one type of setting will need to apply this table to each setting.  
Scoring √ or Y = Yes  X or N = No           NA = Not Applicable  
1. Incidence of TB  
What is the incidence of TB in your community (county or region served by the health-
care setting), and how does it compare with the state and national average? What is the 
incidence of TB in your facility and specific settings and how do those rates compare? 
(Incidence is the number of TB cases in your community the previous year. A rate of TB 
cases per 100,000 persons should be obtained for comparison.)* This information can be 
obtained from the state or local health department.  Community rate_______  
State rate ____________  
National rate _________  
Facility rate __________  
Department 1 rate _______  
Department 2 rate _______  
Department 3 rate _______  
Are patients with suspected or confirmed TB disease encountered in your setting 
(inpatient and outpatient)?  Yes   No  
If yes, how many patients with suspected and confirmed TB disease are treated in your 
health-care setting in 1 year (inpatient and outpatient)? Review laboratory data, infection-
control records, and databases containing discharge diagnoses.  Year  No. patients  
Suspected Confirmed  
1 year ago _____ _____  
2 years ago _____ _____  
5 years ago _____ _____  
If no, does your health-care setting have a plan for the triage of patients with suspected 
or confirmed TB disease?  Yes   No  
Currently, does your health-care setting have a cluster of persons with confirmed TB 
disease that might be a result of ongoing transmission of  




2. Risk Classification 
Inpatient settings   
 How many inpatient beds are in your inpatient setting?
How many patients with TB disease are encountered in the inpatient setting in 1 year? 
Review laboratory data, infection-control records, and databases containing discharge 
diagnoses.  Previous year  ______ 5 years ago ______  
Depending on the number of beds and TB patients encountered in 1 year, what is the risk 
classification for your inpatient setting? (See Appendix C.)  ο Low risk ο Medium 
risk  ο Potential ongoing transmission  
Does your health-care setting have a plan for the triage of patients with suspected or 
confirmed TB disease?  Yes   No  
Outpatient settings   
How many TB patients are evaluated at your outpatient setting in 1 year? Review 
laboratory data, infection-control records, and databases containing discharge diagnoses. 
 Previous year ______ 5 years ago ______  
Is your health-care setting a TB clinic?  
(If yes, a classification of at least medium risk is recommended.)  Yes  No  
Does evidence exist that a high incidence of TB disease has been observed in the 
community that the health-care setting serves?  Yes  No  
Does evidence exist of person-to-person transmission of M. tuberculosis in the health-
care setting? (Use information from case reports. Determine if any tuberculin skin test 
[TST] or blood assay for M. tuberculosis [BAMT] conversions have occurred among 
health-care workers [HCWs]).  Yes  No  
Does evidence exist that ongoing or unresolved health-care–associated  Yes  No  
transmission has occurred in the health-care setting (based on case reports)?   
Is there a high incidence of immunocompromised patients or HCWs in the health-care 
setting?  Yes  No  
Have patients with drug-resistant TB disease been encountered in your healthcare setting 
within the previous 5 years?  Yes  No  
Year ________  
When was the first time a risk classification was done for your health-care setting? 
 __________________  
Considering the items above, would your health-care setting need a higher risk 
classification?  Yes  No  
Depending on the number of TB patients evaluated in 1 year, what is the risk classification 
for your outpatient setting? (See Appendix C)  ο Low risk ο Medium risk ο Potential 
ongoing transmission  
Does your health-care setting have a plan for the triage of patients with suspected or 
confirmed TB disease?  Yes   No   




How many TB patients are encountered at your setting in 1 year?  Previous year 5 years 
ago  ______ ______  
Does evidence exist that a high incidence of TB disease has been observed in the 
community that the setting serves?  Yes  No   
Does evidence exist of person-to-person transmission of M. tuberculosis in the setting? 
 Yes  No   
Have any recent TST or BAMT conversions occurred among staff or clients?  Yes  No 
  
Is there a high incidence of immunocompromised patients or HCWs in the setting? 
 Yes  No   
Have patients with drug-resistant TB disease been encountered in your healthcare setting 
within the previous 5 years?  Yes  No  
Year  ________  
When was the first time a risk classification was done for your setting?   
Considering the items above, would your setting require a higher risk classification? 
 Yes  No  
Does your setting have a plan for the triage of patients with suspected or confirmed TB 
disease?  Yes   No  
Depending on the number of patients with TB disease who are encountered in a 
nontraditional setting in 1 year, what is the risk classification for your setting?  
(See Appendix C)  ο Low risk ο Medium risk ο Potential ongoing transmission  
3. Screening of HCWs for M. tuberculosis Infection  
Does the health-care setting have a TB screening program for HCWs?  Yes  No  
If yes, which HCWs are included in the TB screening program? (Check all that apply.) ο 
Physicians  
ο Mid-level practitioners (nurse practitioners [NP] and physician’s assistants [PA])  
ο Nurses ο Administrators ο Laboratory workers ο Respiratory therapists  ο 
Janitorial staff  
ο Maintenance or engineering staff ο Transportation staff ο Dietary staff ο Receptionists 
ο Trainees and students ο Volunteers  
ο Others_________________  
ο Physical therapists ο Contract staff  
ο Construction or renovation workers ο Service workers  
Is baseline skin testing performed with two-step TST for HCWs?  Yes  No  
Is baseline testing performed with QFT or other BAMT for HCWs?  Yes  No  
How frequently are HCWs tested for M. tuberculosis infection?   
Are the M. tuberculosis infection test records maintained for HCWs?  Yes  No  
Where are the M. tuberculosis infection test records for HCWs maintained? Who 




If the setting has a serial TB screening program for HCWs to test for M. tuberculosis 
infection, what are the conversion rates for the previous years? †  
1 year ago _________________   4 years ago _________________  
2 years ago _________________   5 years ago _________________  
3 years ago _________________  
Has the test conversion rate for M. tuberculosis infection been increasing or decreasing, 
or has it remained the same over the previous 5 years? (check one)  ο Increasing  ο 
Decreasing ο No change   
Do any areas of the health-care setting (e.g., waiting rooms or clinics) or any group of 
HCWs (e.g., lab workers, emergency department staff, respiratory therapists, and HCWs 
who attend bronchoscopies) have a test conversion rate for M. tuberculosis infection that 
exceeds the health-care setting’s annual average?  Yes  No  
If yes, list _________________________  
_________________________________ _________________________________  
For HCWs who have positive test results for M. tuberculosis infection and who leave 
employment at the health setting, are efforts made to communicate test results and 
recommend follow-up of latent TB infection (LTBI) treatment with the local health 
department or their primary physician?  Yes No  Not applicable  
4. TB Infection-Control Program 
 Does the health-care setting have a written TB infection-control plan? 
 Y
es No  
Who is responsible for the infection-control program?   
When was the TB infection-control plan first written?   
When was the TB infection-control plan last reviewed or updated?   
Does the written infection-control plan need to be updated based on the timing of the 
previous update (i.e., >1 year, changing TB epidemiology of the community or setting, 
the occurrence of a TB outbreak, change in state or local TB policy, or other factors related 
to a change in risk for transmission of M. tuberculosis)?  Yes  No  
Does the health-care setting have an infection-control committee (or another committee 
with infection control responsibilities)?  Yes  No  
If yes, which groups are represented on the infection-control  
committee? (Check all that apply.)  ο Laboratory personnel   ο Physicians  ο 
Health and safety staff ο Nurses  ο Administrator    
ο Epidemiologists      ο Risk assessment ο Engineers  ο Quality control (QC) 
ο Pharmacists  ο Others (specify)_________  
If no, what committee is responsible for infection control in the setting?   
5. Implementation of TB Infection-Control Plan Based on Review by Infection-




Has a person been designated to be responsible for implementing an infection-control plan 
in your health-care setting? If yes, list the name: _________________________  Yes  No  
Based on a review of the medical records, what is the average number of days for the 
following:  
• Presentation of patient until collection of specimen  _____  
• Specimen collection until receipt by laboratory    _____  
• Receipt of specimen by laboratory until smear results are provided to health-care 
provider  _____  
• Diagnosis until initiation of standard antituberculosis treatment  _____  
• Receipt of specimen by laboratory until culture results are provided to health-care 
provider   _____  
• Receipt of specimen by laboratory until drug-susceptibility results are provided to   
 health-care provider  _____  
• Receipt of drug-susceptibility results until adjustment of antituberculosis treatment,  
    if indicated   _____  
• Admission of patient to hospital until placement in airborne infection isolation (AII) 
 _____  
Through what means (e.g., review of TST or BAMT conversion rates, patient medical 
records, and time analysis) are lapses in infection control recognized?   
What mechanisms are in place to correct lapses in infection control?   
Based on measurement in routine QC exercises, is the infection-control plan being 
properly implemented?  Yes  No  
Is ongoing training and education regarding TB infection control practices provided for 
HCWs?  Yes  No  
Which environmental controls are in place in your health-care setting? (Check all that 
apply and describe)   
Environmental control  Description ο AII rooms     _____________________  
6. Laboratory Processing of TB-Related Specimens, Tests, and Results Based on 
Laboratory Review  
Which of the following tests are either conducted in-house at your healthcare setting’s 
laboratory or sent out to a reference laboratory?  In-house  Sent out  
Acid-fast bacilli (AFB) smears     
Culture using liquid media (e.g., Bactec and MB-BacT)     
Culture using solid media     
Drug-susceptibility testing    
Nucleic acid amplification (NAA) testing     
What is the usual transport time for specimens to reach the laboratory for the following 
tests?  
 AFB smears    ___________  




 Culture using solid media      ___________  
 Drug-susceptibility testing  ___________  
 Other (specify)  ___________  
 NAA testing  ___________  
Does the laboratory at your health-care setting or the reference laboratory used by your 
health-care setting report AFB smear results for all patients within 24 hours of receipt of 
specimen? Yes  No  
What is the procedure for weekends?   
 
7. Environmental Controls  
 
ο Local exhaust ventilation (enclosing devices and exterior devices)  
 _____________________ ο General ventilation (e.g., single-pass system, 
recirculation system.)    _____________________  
ο Air-cleaning methods (e.g., high-efficiency particulate air [HEPA] filtration and 
ultraviolet germicidal irradiation [UVGI]) 
___________________________________________________________  
What are the actual air changes per hour (ACH) and design for various rooms in the 
setting?  
 Room  ACH  Design  
Which of the following local exterior or enclosing devices such as exhaust ventilation 
devices are used in your health-care setting? (Check all that apply) ο Laboratory hoods ο 
Booths for sputum induction   
ο Tents or hoods for enclosing patient or procedure   
What general ventilation systems are used in your health-care setting? (Check all that 
apply) ο Single-pass system ο Variable air volume (VAV) ο Constant air volume (CAV) 
ο Recirculation system ο Other____________________  
What air-cleaning methods are used in your health-care setting? (Check all that apply)  
HEPA filtration ο Fixed room-air recirculation systems ο Portable room-air recirculation 
systems   
UVGI  
ο Duct irradiation ο Upper-air irradiation ο Portable room-air cleaners  
How many AII rooms are in the health-care setting?   
What ventilation methods are used for AII rooms? (Check all that apply) Primary (general 
ventilation):  
ο Single-pass heating, ventilating, and air conditioning (HVAC) ο Recirculating HVAC 
systems         
Secondary (methods to increase equivalent ACH):  
ο Fixed room recirculating units     ο HEPA filtration ο UVGI  




Does your health-care setting employ, have access to, or collaborate with an 
environmental engineer (e.g., professional engineer) or other professional with 
appropriate expertise (e.g., certified industrial hygienist) for consultation on design 
specifications, installation, maintenance, and evaluation of environmental controls? 
 Yes  No  
Are environmental controls regularly checked and maintained with results recorded in 
maintenance logs?  Yes  No  
Are AII rooms checked daily for negative pressure when in use?  Yes  No  
Is the directional airflow in AII rooms checked daily when in use with smoke tubes or 
visual checks?  Yes  No  
Are these results readily available?  Yes No  
What procedures are in place if the AII room pressure is not negative? 
 ______________________________________  
Do AII rooms meet the recommended pressure differential of 0.01-inch water column 
negative to surrounding structures?  Yes  No  
8. Respiratory-Protection Program  
Does your health-care setting have a written respiratory-protection program?  Yes No  
Which HCWs are included in the respiratory protection program? (Check all that apply) 
ο Physicians  
ο Mid-level practitioners (NPs and PAs) ο Nurses ο Administrators ο Laboratory 
personnel  
ο Contract staff  
ο Construction or renovation staff ο Service personnel  ο Janitorial staff  
ο Maintenance or engineering staff 
ο Transportation staff ο Dietary staff  ο Students  
ο Others (specify)_____________ ___________________________ 
Are respirators used in this setting for HCWs working with TB patients? If yes, include 
m model, and specific application (e.g., ABC model 1234 for bronchoscopy and DEF 
model contact with infectious TB patients).  
   Manufacturer   Model   Specific application  Manufacturer, 5678 for 
routine 
  
Is annual respiratory-protection training for HCWs performed by a person with advanced 
training in respiratory protection?  Yes  No  
Does your health-care setting provide initial fit testing for HCWs? If yes, when is it 
conducted? ____________________________ Yes No  
Does your health-care setting provide periodic fit testing for HCWs?  
If yes, when and how frequently is it conducted? ____________________________ 
 Yes No  




Is qualitative fit testing used?  Yes  No  
Is quantitative fit testing used?  Yes  No  
9. Reassessment of TB risk  
How frequently is the TB risk assessment conducted or updated in the health-care setting? 
  
When was the last TB risk assessment conducted?  
What problems were identified during the previous TB risk assessment?  
 
What actions were taken to address the problems identified during the previous TB risk 
assessment?  
 
Did the risk classification need to be revised as a result of the last TB risk assessment?  
 Yes  No  
*  If the population served by the health-care facility is not representative of the 
community in which the facility is located, an alternate comparison population might be 
appropriate.   
† Test conversion rate is calculated by dividing the number of conversions among 
HCWs by the number of HCWs who were tested and had prior negative results during a 





APPENDIX D: TUBERCULOSIS BASELINE PERSONNEL ASSESSMENT 
BOX. Indicators of risk* for tuberculosis (TB) at baseline health care personnel assessment† 
Health care personnel should be considered to be at increased risk for TB if they answer “yes” to 
any of the following statements. 
1. Temporary or permanent residence (for ≥1 month) in a country with a high TB rate (i.e., any 
country other than Australia, Canada, New Zealand, the United States, and those in western or 
northern Europe) 
Or 
2. Current or planned immunosuppression, including human immunodeficiency virus infection, 
receipt of an organ transplant, treatment with a TNF-alpha antagonist (e.g., infliximab, 
etanercept, or other), chronic steroids (equivalent of prednisone ≥15 mg/day for ≥1 month), or 
other immunosuppressive medication 
Or 
3. Close contact with someone who has had infectious TB disease since the last TB test 
Abbreviation: TNF = tumor necrosis factor. 
* Individual risk assessment information can be useful in interpreting TB test results. Lewinsohn 
DM, Leonard MK, LoBue PA, et al. Official American Thoracic Society/Infectious Diseases Society 
of America/Centers for Disease Control and Prevention clinical practice guidelines: diagnosis of 
tuberculosis in adults and children. Clin Infec Dis 2017;64:111–5). 
https://academic.oup.com/cid/article/64/2/111/2811357external icon 
† Adapted from a tuberculosis risk assessment form developed by the California Department of 
Public Health. 
https://www.cdph.ca.gov/Programs/CID/DCDC/CDPH%20Document%20Library/TBCB-CA-TB-
Risk-Assessment-and-Fact-Sheet.pdfpdf iconexternal icon. 
Suggested citation for this article: Sosa LE, Njie GJ, Lobato MN, et al. Tuberculosis Screening, 
Testing, and Treatment of U.S. Health Care Personnel: Recommendations from the National 
Tuberculosis Controllers Association and CDC, 2019. MMWR Morb Mortal Wkly Rep 2019; 
68:439–443. DOI: http://dx.doi.org/10.15585/mmwr.mm6819a3external icon.  
